References
- Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19, 217–224, 2012.10.1245/s10434-011-1814-021638095
- Chen Q, Yang LX, Li XD, Yin D, Shi SM, Chen EB, Yu L, Zhou ZJ, Zhou SL, Shi YH, Fan J, Zhou J, Dai Z. The elevated preoperative neutrophil-to-lmyphocyte ration predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumour Biol 36, 5283–5289, 2015.10.1007/s13277-015-3188-625672606
- Coussens LM, Werb Z. Inflammation and cancer. Nature 420, 860–867, 2002.10.1038/nature01322280303512490959
- Duzlu M, Karamert R, Tutar H, Karaloglu F, Sahin M, Cevizci R. Neutrophil-lymphocyte ratio findings and larynx carcinoma: a preliminary study in Turkey. Asian Pac J Cancer Prev 16, 351–354, 2015.10.7314/APJCP.2015.16.1.351
- Forget P, Dinant V, De Kock M. Is the neutrophil-to-lymphocyte ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery? Peer J 3, e713, 2015.10.7717/peerj.713430485425653901
- Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88, 218–230, 2013.10.1016/j.critrevonc.2013.03.01023602134
- Ji WH, Jiang YH, Ji YL, Mao WM. Prechemotherapy neutrophil: lymphocyte ratio is superior to the platelet: lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 29, 403–411, 2016.10.1111/dote.1232225625421
- Jung MR, Park YK, Jeong O, Seon JW, Ryu SY, Kim DY, Kim YJ. Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 104, 504–510, 2011.10.1002/jso.2198621618251
- Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 46, 526–531, 2014.10.1007/s12020-013-0089-624272600
- Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16, 614–622, 2009.10.1245/s10434-008-0267-619130139
- Lang B, Lo CY, Chan WF, Lam KY, Wan KY. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability. Ann Surg Oncol 14, 1551–1559, 2007.10.1245/s10434-006-9242-217318278
- Lang BH, Ng CP, Au KB, Wong KP, Wong KK, Wan KY. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma? World J Surg 38, 2605–2612, 2014.10.1007/s00268-014-2630-z24809487
- Langsenlehner T, Thurner EM, Krenn-Piko S, Langsenlehner U, Stojakovic T, Gerger A, Pichler M. Validation of the neutrophil-to-lymphocyte ration as a prognostic factor in an cohort of European prostate cancer patients. World J Urol 33, 1661–1667, 2015.10.1007/s00345-015-1494-725617235
- Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP. Blood neutrophil-to-lymphocyte ration correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 107, 493–497, 2013.10.1002/jso.2327022996403
- McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev 39, 534–540, 2013.10.1016/j.ctrv.2012.08.00322995477
- Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103, 12493–12498, 2006.10.1073/pnas.0601807103153164616891410
- Okamura Y, Ashida R, Ito T, Sugiura T, Mori K, Uesaka K. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepaticellular carcinoma. World J Surg 39, 1501–1509, 2015.10.1007/s00268-015-2982-z25670038
- Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinoma in thyroidal goiters: a pilot study. Am J Surg 205, 691–696, 2013.10.1016/j.amjsurg.2012.08.00623388425
- Song Y, Liu H, Gao L, Liu X, Ma L, Lu M, Gao Z. Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resections. J Craniofac Surg 26, e137–e140, 2015.10.1097/SCS.000000000000123525643330
- Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Friesenbichler J, Stojakovic T, Leithner A, Pichler M. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients. Am J Surg 210, 111–116, 2015.10.1016/j.amjsurg.2014.10.02125586599
- Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ. Platelet-to-lymphocyte ration better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 17, 391–396, 2013.10.1111/hdi.1204023522328
- Tuttle RM. Differentiated thyroid cancer: Overview of management. UpToDate, Wolters Kluwer (Eds. Ross DS, Mulder JE), 2017.
- Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neuthrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91, 181–184, 2005.10.1002/jso.2032916118772
- Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H. The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2, 735–740, 2011.10.3892/ol.2011.304340633722848258
- Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904–5912, 2008.10.1038/onc.2008.271368926718836471